Artykuły w czasopismach na temat „Drug selection”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Drug selection”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Podrid, P. J. "Antiarrhythmic Drug Selection." Annual Review of Medicine 38, no. 1 (1987): 1–17. http://dx.doi.org/10.1146/annurev.me.38.020187.000245.
Pełny tekst źródłaKlunker, W. "Boenninghausen's drug selection." British Homoeopathic journal 85, no. 1 (1996): 41. http://dx.doi.org/10.1016/s0007-0785(96)80038-x.
Pełny tekst źródłaCrumrine, Patricia K. "Antiepileptic Drug Selection in Pediatric Epilepsy." Journal of Child Neurology 17, no. 2_suppl (2002): 2S2–2S8. http://dx.doi.org/10.1177/08830738020170020701.
Pełny tekst źródłaBrook, Robert D. "Drug selection in hypertension." ACC Current Journal Review 13, no. 12 (2004): 21–26. http://dx.doi.org/10.1016/j.accreview.2004.11.003.
Pełny tekst źródłaUsmonova., M. K., F. X. Maksudova., and A. M. Usubbaev. "DEKSKETOPROFEN TRAMETAMOL CAPSULE DRUG FORM COMPOSITION SELECTION AND TECHNOLOGY DEVELOPMENT." American Journal Of Biomedical Science & Pharmaceutical Innovation 3, no. 12 (2023): 6–13. http://dx.doi.org/10.37547/ajbspi/volume03issue12-02.
Pełny tekst źródłaMitchell, Aaron Philip, Aaron Winn, and Stacie Dusetzina. "Pharmaceutical industry payments and oncologist drug selection." Journal of Clinical Oncology 35, no. 15_suppl (2017): 6510. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.6510.
Pełny tekst źródłaPutri, Awanda Octavianti, and Eka Prasetyaningrum. "Sistem Pendukung Keputusan Pemilihan Supplier Dengan Metode AHP Pada Apotek & Laboratorium Klinik Interna Berbasis Web." JURNAL MEDIA INFORMATIKA BUDIDARMA 5, no. 4 (2021): 1353. http://dx.doi.org/10.30865/mib.v5i4.3236.
Pełny tekst źródłasah, Sushilkumar, Dr AjayKumar Tiwari, and Prof B. Shrivastava. "FLOATING DRUG DELIVERY SYSTEMS: RATIONALE FOR DRUG SELECTION." International Journal of Advanced Research 4, no. 10 (2016): 127–33. http://dx.doi.org/10.21474/ijar01/1768.
Pełny tekst źródłaLu, Da-Yong, and Ting-Ren Lu. "Drug sensitivity testing, a unique drug selection strategy." Advances in Biomarker Sciences and Technology 2 (2020): 59–66. http://dx.doi.org/10.1016/j.abst.2020.11.001.
Pełny tekst źródłaBanerjee, I., A. Saha, B. Sathian, B. Roy, and I. Banerjee. "Evaluation of Medical students perception on Personal Drug Selection for improving prospective Medical Education: A situational Analysis from Manipal College of Medical Sciences, Pokhara, Nepal." Nepal Journal of Medical Sciences 3, no. 2 (2015): 89–93. http://dx.doi.org/10.3126/njms.v3i2.13450.
Pełny tekst źródłaMaria, Nisa, Ferlina Vidyananda Susilo, and Mayannaria Simarmata. "Drug Selection, Dosage Adjustment, and Potential Interaction of Antihypertensive and Antidiabetic for Chronic Kidney Disease with Hemodialysis." JURNAL ILMU KEFARMASIAN INDONESIA 21, no. 2 (2023): 254. http://dx.doi.org/10.35814/jifi.v21i2.1484.
Pełny tekst źródłaWijaya, Dhani, Sadli Syarifuddin, Atiqoh Nur Habibah, et al. "Drug-related problems (DRPs) in hypertensive patients at Karsa Husada Batu Hospital, East Java, Indonesia: Evaluation based on drug selection." Pharmacy Education 24, no. 3 (2024): 412–17. http://dx.doi.org/10.46542/pe.2024.243.412417.
Pełny tekst źródłaBanerjee, Indrajit. "Concepts of P Drug Selection." Nepal Journal of Epidemiology 3, no. 1 (2013): 226–29. http://dx.doi.org/10.3126/nje.v3i1.8280.
Pełny tekst źródłaKnowles, Jonathan, and Gianni Gromo. "Target selection in drug discovery." Nature Reviews Drug Discovery 2, no. 1 (2003): 63–69. http://dx.doi.org/10.1038/nrd986.
Pełny tekst źródłaHarrigan, P. Richard, and Christopher S. Alexander. "Selection of drug-resistant HIV." Trends in Microbiology 7, no. 3 (1999): 120–23. http://dx.doi.org/10.1016/s0966-842x(99)01467-5.
Pełny tekst źródłaChristensen, Thomas P., Duane M. Kirking, Frank J. Ascione, Lynda S. Welage, and Caroline A. Gaither. "Drug Product Selection: Legal Issues." Journal of the American Pharmaceutical Association (1996) 41, no. 6 (2001): 868–74. http://dx.doi.org/10.1016/s1086-5802(16)31328-6.
Pełny tekst źródłaIqbal, Mir Javid, Mohammad Ishaq Geer, and Parvez Ahamd Dar. "DEVELOPMENT OF AN INDICATOR BASED TOOL FOR THE ASSESSMENT OF MEDICINES SELECTION PRACTICES IN VARIOUS PUBLIC SECTOR HOSPITALS." International Journal of Pharmacy and Pharmaceutical Sciences 8, no. 11 (2016): 205. http://dx.doi.org/10.22159/ijpps.2016v8i11.14536.
Pełny tekst źródłaCheng, Lijun, Bryan P. Schneider, and Lang Li. "A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients." Journal of the American Medical Informatics Association 23, no. 4 (2016): 741–49. http://dx.doi.org/10.1093/jamia/ocw004.
Pełny tekst źródłaChen, Lei, Kaiyu Chen, and Bo Zhou. "Inferring drug-disease associations by a deep analysis on drug and disease networks." Mathematical Biosciences and Engineering 20, no. 8 (2023): 14136–57. http://dx.doi.org/10.3934/mbe.2023632.
Pełny tekst źródłaG., Priyadarshini Bai, and Ravi Kumar P. "A study on concept of P- drug selection among rural general practitioners." International Journal of Basic & Clinical Pharmacology 6, no. 1 (2016): 155. http://dx.doi.org/10.18203/2319-2003.ijbcp20164772.
Pełny tekst źródłaTuti, Sri Dias, Umi Athiyah, and Wahyu Utami. "Factors Affecting The Drugs Availability on Program Rujuk Balik (PRB) at PRB Drugs Facility in Ex Karesidenan Kediri (Study of Hipertension Drugs)." JURNAL ILMU KEFARMASIAN INDONESIA 16, no. 1 (2018): 30. http://dx.doi.org/10.35814/jifi.v16i1.437.
Pełny tekst źródłaKumar, Manish, Lalit Mohan, Hitesh Mishra, Akash Chandra, and Harihar Dikshit. "Students’ attitudes on personal drug selection exercise in writing prescription." International Journal of Basic & Clinical Pharmacology 7, no. 1 (2017): 147. http://dx.doi.org/10.18203/2319-2003.ijbcp20175691.
Pełny tekst źródłaFaizullin, Sh B., and M. S. Musin. "Principles of rational selection and use of drug combinations." Kazan medical journal 67, no. 5 (1986): 397–400. http://dx.doi.org/10.17816/kazmj70726.
Pełny tekst źródłaBottery, Michael J., A. Jamie Wood, and Michael A. Brockhurst. "Selective Conditions for a Multidrug Resistance Plasmid Depend on the Sociality of Antibiotic Resistance." Antimicrobial Agents and Chemotherapy 60, no. 4 (2016): 2524–27. http://dx.doi.org/10.1128/aac.02441-15.
Pełny tekst źródłaMrazek, David A. "The Context of Genetic Testing in Clinical Psychiatric Practice." CNS Spectrums 11, S3 (2006): 3–4. http://dx.doi.org/10.1017/s1092852900025578.
Pełny tekst źródłaNtafoulis, Ioannis, Stijn L. W. Koolen, Olaf van Tellingen, et al. "A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma." Pharmaceuticals 17, no. 12 (2024): 1687. https://doi.org/10.3390/ph17121687.
Pełny tekst źródłaBeilstein, Sabina, Radhia El Phil, Suzanne Sahraoui, Leonardo Scapozza, Marcel Kaiser, and Pascal Mäser. "Laboratory Selection of Trypanosomatid Pathogens for Drug Resistance." Pharmaceuticals 15, no. 2 (2022): 135. http://dx.doi.org/10.3390/ph15020135.
Pełny tekst źródłaMott, David A., Jon C. Schommer, William R. Doucette, and David H. Kreling. "Agency Theory, Drug Formularies, and Drug Product Selection: Implications for Public Policy." Journal of Public Policy & Marketing 17, no. 2 (1998): 287–95. http://dx.doi.org/10.1177/074391569801700211.
Pełny tekst źródłaBelialov, F. I. "Selection of medications in comorbidity." Russian Archives of Internal Medicine 10, no. 1 (2020): 57–60. http://dx.doi.org/10.20514/2226-6704-2020-10-1-57-60.
Pełny tekst źródłaTillie, Nicole A., Jayson L. Parker, and Jordan J. Feld. "Clinical Trial Risk in Hepatitis C: Endpoint Selection and Drug Action." Canadian Journal of Gastroenterology and Hepatology 2016 (2016): 1–7. http://dx.doi.org/10.1155/2016/6260271.
Pełny tekst źródła&NA;. "Appropriate drug selection minimises performance impairment." Reactions Weekly &NA;, no. 427 (1992): 3. http://dx.doi.org/10.2165/00128415-199204270-00005.
Pełny tekst źródłaShankar, Ravi P. "P-drug selection: Choosing medicines objectively." Nepal Journal of Epidemiology 3, no. 2 (2013): 251. http://dx.doi.org/10.3126/nje.v3i2.8510.
Pełny tekst źródłaFlammer, Keven. "Antibiotic Drug Selection in Companion Birds." Journal of Exotic Pet Medicine 15, no. 3 (2006): 166–76. http://dx.doi.org/10.1053/j.jepm.2006.06.003.
Pełny tekst źródłaAppelbaum, Peter C. "Resistance amongStreptococcus pneumoniae:Implications for Drug Selection." Clinical Infectious Diseases 34, no. 12 (2002): 1613–20. http://dx.doi.org/10.1086/340400.
Pełny tekst źródłaPODRID, P. "Systematic approach to antiarrhythmic drug selection." Journal of Molecular and Cellular Cardiology 18 (1986): 57. http://dx.doi.org/10.1016/s0022-2828(86)80200-0.
Pełny tekst źródłaLi, Gang, Yining Wang, and S. Peter Ouyang. "Interim Treatment Selection in Drug Development." Statistics in Biosciences 1, no. 2 (2009): 268–88. http://dx.doi.org/10.1007/s12561-009-9017-y.
Pełny tekst źródłaKaminski, James J. "Computer-assisted drug design and selection." Advanced Drug Delivery Reviews 14, no. 2-3 (1994): 331–37. http://dx.doi.org/10.1016/0169-409x(94)90049-3.
Pełny tekst źródłaYang, Yanling. "Drug Selection Preference in Hypertensive Patients." Metabolism 104 (March 2020): 154094. http://dx.doi.org/10.1016/j.metabol.2019.12.040.
Pełny tekst źródłaHe, Jiang, and Paul K. Whelton. "Selection of initial antihypertensive drug therapy." Lancet 356, no. 9246 (2000): 1942–43. http://dx.doi.org/10.1016/s0140-6736(00)03300-6.
Pełny tekst źródłaBroughton, Howard B., and Ian A. Watson. "Selection of heterocycles for drug design." Journal of Molecular Graphics and Modelling 23, no. 1 (2004): 51–58. http://dx.doi.org/10.1016/j.jmgm.2004.03.016.
Pełny tekst źródłaArmstrong, Edward P., Alexander Bykov, and Anthony V. Savelli. "Introducing formulary drug selection in Russia." American Journal of Health-System Pharmacy 53, no. 4 (1996): 426–28. http://dx.doi.org/10.1093/ajhp/53.4.426.
Pełny tekst źródłaBarends, Clemens R. M., Anthony R. Absalom, and Michel M. R. F. Struys. "Drug selection for ambulatory procedural sedation." Current Opinion in Anaesthesiology 31, no. 6 (2018): 673–78. http://dx.doi.org/10.1097/aco.0000000000000652.
Pełny tekst źródłaBHATHENA, A., and B. SPEAR. "Pharmacogenetics: improving drug and dose selection." Current Opinion in Pharmacology 8, no. 5 (2008): 639–46. http://dx.doi.org/10.1016/j.coph.2008.07.013.
Pełny tekst źródłaMuegge, Ingo. "Selection criteria for drug-like compounds." Medicinal Research Reviews 23, no. 3 (2003): 302–21. http://dx.doi.org/10.1002/med.10041.
Pełny tekst źródłaCarey, Robert M. "Is Personalized Antihypertensive Drug Selection Feasible?" JAMA 329, no. 14 (2023): 1153. http://dx.doi.org/10.1001/jama.2023.3704.
Pełny tekst źródłaPerbawawati, Anna Adi, Endang Sugiharti, and Much Aziz Muslim. "Bayes Theorem and Forward Chaining Method On Expert System for Determine Hypercholesterolemia Drugs." Scientific Journal of Informatics 6, no. 1 (2019): 116–24. http://dx.doi.org/10.15294/sji.v6i1.14149.
Pełny tekst źródłaFanita, Dina, and Bosker Sinaga. "Supplier Selection Decision Support System Drug Wighted Methods Product (WP)." Journal Of Computer Networks, Architecture and High Performance Computing 2, no. 1 (2020): 135–39. http://dx.doi.org/10.47709/cnapc.v2i1.377.
Pełny tekst źródłaPark, Andrew W., James Haven, Ray Kaplan, and Sylvain Gandon. "Refugia and the evolutionary epidemiology of drug resistance." Biology Letters 11, no. 11 (2015): 20150783. http://dx.doi.org/10.1098/rsbl.2015.0783.
Pełny tekst źródłaVandeWaa, Elizabeth A., and Carolyn Dolan. "Mindful Prescribing: Drug Development, Drug Selection, and Advanced Nursing Practice." Journal for Nurse Practitioners 16, no. 3 (2020): 186–90. http://dx.doi.org/10.1016/j.nurpra.2019.12.014.
Pełny tekst źródłaBöger, R. H. "Drug interactions of the statins and consequences for drug selection." Int. Journal of Clinical Pharmacology and Therapeutics 39, no. 09 (2001): 369–82. http://dx.doi.org/10.5414/cpp39369.
Pełny tekst źródła